Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma

Published:2015-11 Issue:6 Volume:17 Page:652-660
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Drandi Daniela,Kubiczkova-Besse Lenka,Ferrero Simone,Dani Nadia,Passera Roberto,Mantoan Barbara,Gambella Manuela,Monitillo Luigia,Saraci Elona,Ghione Paola,Genuardi Elisa,Barbero Daniela,Omedè Paola,Barberio Davide,Hajek Roman,Vitolo Umberto,Palumbo Antonio,Cortelazzo Sergio,Boccadoro Mario,Inghirami Giorgio,Ladetto Marco

Funder

Ministero Italiano dell'Università e della Ricerca

Progetti di Ricerca Finalizzata 2008

IRCCS Centro di Riferimento Oncologico della Basilicata

Progetto di Ricerca Sanitaria Finalizzata

Multiple Myeloma Research Foundation

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference44 articles.

1. Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival;Ferrero;Leukemia,2015

2. Minimal residual disease detection in mantle cell lymphoma: technical aspects and clinical relevance;Pott;Semin Hematol,2011

3. Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma;Ladetto;J Clin Oncol,2010

4. Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study;Pott;Blood,2010

5. Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program;Ladetto;Blood,2013

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review;The Journal of Liquid Biopsy;2024-09

2. Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?;Blood Reviews;2024-08

3. Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia;Cancers;2024-05-28

4. Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective study;Journal of Translational Medicine;2024-04-30

5. Defining an Optimized Workflow for Enriching and Analyzing Residual Tumor Populations Using Intracellular Markers;The Journal of Molecular Diagnostics;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3